6 小时
MyChesCo on MSNChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy ManufacturingChromaTan Inc. and Landmark Bio PBLLC have been awarded a grant from the National Institute for Innovation in Manufacturing ...
Previous efforts to circumvent the problem of the size limitation imposed by the AAV vector have focused mainly on altering the candidate genes into ‘mini-expression cassettes’ suitable for ...
Adeno-associated viral (AAV) vectors in particular have high transduction rates and reduced toxicity concerns compared to other viral vectors. However, these delivery vehicles present some application ...
Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.
AAV vectors have a low immunogenicity profile ... To address these challenges, researchers are developing novel viral vector designs, such as self-inactivating vectors, tissue-specific promoters, and ...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce a Request for Applications (RFA) to participate in its Viral Vector Program's initiative on ...
To ensure they have the materials required for each testing phase, researchers can also rely on off-the-shelf plasmid and viral vector solutions, such as those offered by Charles River as a part of ...
ProBioGen has expanded its protein and viral vector manufacturing capabilities at its Berlin headquarters, reinforcing its ...
The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...
The viral vector analysis module in ASTRA software, provided by Wyatt Technology, calculates several AAV-specific CQAs: the total AAV genomic concentration Vg, the AAV capsid concentration Cp ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果